A director at Scandic Hotels Group AB maiden bought 20,000 shares at 76.940SEK and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Last week the board of Cofinimmo did not recommend the voluntary exchange offer of Aedifica at a 1.16x ratio. Now, Cofinimmo believes a 1.21x exchange ratio would be a better balance for its shareholders. Aedifica did not yet agree to the new terms. We (KBC) believe it made sense for Aedifica to at least wait for their AGM yesterday to comment. According to De Tijd (BE newspaper), there was an indication that Aedifica would not increase its bid as it continues to believe the initial offer is fai...
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States Saint Herblain (France), May, 12 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a joint to the medical community, have recommended a pause in the use of Valneva’s single-dose live attenuated chikungunya vaccine IXCHIQ® in elderly individuals while ongoing investigations into reported serious adverse events (SAEs) are completed. This update f...
Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les personnes âgées aux États-Unis Saint Herblain (France), le 12 mai 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence de santé américaine Food and Drug Administration (FDA) et les centres américains de contrôle et de prévention des maladies (CDC) ont recommandé à la communauté médicale américaine dans une communication conjointe de suspendre l'utilisation du vaccin vivant atténué à dose unique contre le chikungunya de Valneva, IXCHIQ®, chez les ...
Aedifica, Cofinimmo: Aedifica CMD feedback bpost: 1Q25 results beat strongly, outlook surprises Brunel: 1Q25 results disappoint on perm, weak revenue Cofinimmo, Aedifica: Negative reaction on Aedifica offer Eurocommercial Properties: Good with no surprise Montea: Good results, guidance reconfirmed Proximus: Small 1Q beat, guidance reiterated, soft commercial performance Sif Group: The jury is still out Talabat: Preview 1Q25 Universal Music Group: Peer Warner Music slowdown in streaming and prof...
A director at Cofinimmo sold 2,600 shares at 77.399EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
AMG Announces Results of its 2025 Annual General Meeting Amsterdam, 8 May 2025 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that during its Annual General Meeting held on May 8, 2025, shareholders approved all agenda items presented. During the meeting, Dr. Heinz Schimmelbusch was reappointed as Chief Executive Officer for an additional term of two years, beginning May 8, 2025. At this Annual General Meeting, the term of AMG’s Chief Operating Officer, Mr. Eric Jackson, has ended and he has indicated his plan to retire. Mr...
AMG Announces Final 2024 Dividend Amsterdam, 8 May 2025 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that during the Annual General Meeting, held on May 8, 2025, AMG's shareholders approved the payment of a dividend of €0.40 per ordinary share over the financial year 2024. The interim dividend of €0.20, paid on August 14, 2024, was deducted from the amount distributed to shareholders. The final dividend per ordinary share therefore amounts to €0.20. Payment of the final dividend will be completed on or around May 15, 202...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.